MarketScreener Homepage > Equities > London Stock Exchange > ConvaTec Group Plc CTEC GB00BD3VFW73

Report

Delayed London Stock Exchange - 01/15 11:35:24 am
199.2	GBX		-1.19%

01/04

CONVATEC : JPMorgan Raises Convatec To Neutral From Underweight, Ups PT

2020

Moody's Affirms Convatec's Ratings, Changes Outlook To Positive On Improved Operating, Financial Trading

2020

CONVATEC : Q3 Trading update for the three months ended 30 September 2020

Summary

Quotes 5-day view Delayed Quote.

Delayed London Stock Exchange

01/11/2021	01/12/2021	01/13/2021	01/14/2021	01/15/2021	Date
204.6(c)	203.6(c)	203.2(c)	201.2(c)	199.2(c)	Last
2 047 690	1 727 697	1 921 116	2 389 331	2 011 283	Volume
-1.45%	-0.49%	-0.20%	-0.98%	-0.99%	Change

More quotes

Financials (USD)

Sales 2020	1 880 M - -
Net income 2020	88,3 M - -
Net Debt 2020	1 005 M - -
P/E ratio 2020	50,3x
Yield 2020	1,96%

Sales 2021	1 944 M - -
Net income 2021	137 M - -
Net Debt 2021	874 M - -
P/E ratio 2021	37,4x
Yield 2021	2,16%

Capitalization	5 411 M 5 414 M -
EV / Sales 2020	3,41x
EV / Sales 2021	3,23x
Nbr of Employees	9 197
Free-Float	79,7%

More Financials

Company

ConvaTec Group specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, incontinence and critical care. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (32.7%): antimicrobial dressings, occlusive dressings, compression bandages, etc. ; - ostomy care (30%): skin barriers, one-piece bags,...

Sector

Medical Equipment, Supplies & Distribution

Calendar

03/05

Ergebnisveröffentlichung

More about the company

Notations Surperformance© of ConvaTec Group Plc

Trading Rating :

Investor Rating :

More Ratings

All news about CONVATEC GROUP PLC

01/04	CONVATEC : JPMorgan Raises Convatec To Neutral From Underweight, Ups PT	MT
2020	Moody's Affirms Convatec's Ratings, Changes Outlook To Positive On Improved O..	MT
2020	CONVATEC : Q3 Trading update for the three months ended 30 September 2020	PU
2020	CONVATEC : Trading update for the three months ended 30 September 2020 28 Octobe..	PU
2020	CONVATEC : Interim Results for the 6 months ended 30 June 2020 06 August 2020	PU
2020	CONVATEC : Constantin Coussios FREng appointed Non-Executive Director 13 July 20..	PU
2020	CONVATEC : PHARMAC - Proposal to list medical devices supplied by ConvaTec Limit..	AQ
2020	CONVATEC : Board changes 29 May 2020	PU
2020	CONVATEC : Heather Mason appointed Non-Executive Director 11 May 2020	PU
2020	CONVATEC : Trading update for the three months ended 31 March 2020 30 April 2020	PU
2020	CONVATEC GROUP PLC : 1st quarter earnings	CO
2020	CONVATEC : PHARMAC - Decision to list medical devices supplied by ConvaTec New Z..	AQ
2020	CONVATEC : 2019 Annual Report & Accounts and Notice of AGM	PU
2020	CONVATEC : Annual Report and Accounts for the year ended 31 December 2019	PU
2020	ANNUAL RESULTS FOR THE YEAR ENDED 31 : Presentation Deck	PU

More news

News in other languages on CONVATEC GROUP PLC

01/04	Georgia on my mind
01/04	AVIS D'ANALYSTES DU JOUR : Adyen, Atos, Alcon, Equinor, Rémy Cointreau, Roche, T..
2020	HEATMAP STOXX EUROPE 600 : les industrielles flanchent, la distanciation sociale..
2020	L'Euro en quarantaine
2020	AVIS D'ANALYSTES DU JOUR : Boohoo, DiaSorin, Elior, Euronext, HelloFresh, Melexi..

More news

Analyst Recommendations on CONVATEC GROUP PLC

01/04	CONVATEC : JPMorgan Raises Convatec To Neutral From Underweight, Ups PT	MT
2017	Financials dampen FTSE as broker action dominates	RE
2017	FTSE 100 gets sterling boost while Barclays dives after results	RE

More recommendations

Provided by Scoopnest.com

Chart CONVATEC GROUP PLC

Duration : Period :

ConvaTec Group Plc Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends CONVATEC GROUP PLC

	Short Term	Mid-Term	Long Term
Trends	Bearish	Bullish	Neutral

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	17
Average target price	2,92 $
Last Close Price	2,71 $
Spread / Highest target	34,0%
Spread / Average Target	7,75%
Spread / Lowest Target	-20,2%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Karim Sani Nasib Bitar	Chief Executive Officer & Director
John David Gibson McAdam	Chairman
Donal Balfe	Executive Vice President-Global Operations
Frank M. Schulkes	Chief Financial Officer & Director
Robert Steele	EVP-Quality, Clinical & Regulatory Affairs

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

CONVATEC GROUP PLC	0.00%	5 414



ABBOTT LABORATORIES	1.65%	190 701
MEDTRONIC PLC	-0.28%	157 229
BECTON, DICKINSON AND COMPANY	4.60%	76 127
HOYA CORPORATION	-2.24%	50 041
ALIGN TECHNOLOGY, INC.	6.15%	44 726

More Results